Impact Factor
2.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.92
23 total citations
h5-index
5
h5 depth signal
Cited share
41.7%
5 of 12
Total citations
23
Citation footprint
Metric signal
2.75
External metric anchor
Self-citation
4.3%
1 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
42
United Kingdom
3
Canada
1
Greece
1
India
1
Citing Fields of Research
Healthcare Policy
35
Economics
23
Medical Ethics
23
Patient Care
15
Health Education & Remote Healthcare
6
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
271
Articles tracked across the journal lifetime
Indexed publication set
12
5 cited publications
Last 12 months
4
2.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
United States
42 citing publications
Leading citing field
Healthcare Policy
35 citing publications
Latest tracked publication
1 June 2026
10 recent records available
Coverage & Indexing History
v21n1, June 2018-
v21n1, June 2018-
Research Focus & Classification
Indexed Subjects
Medical Ethics
Transplantation
Healthcare Policy
Economics
Issuing & Sponsoring Bodies
Contributor
National Bureau of Economic Research
Broad Categories
Public Health
Medical Ethics
Nicotine Addiction Treatment
MeSH Descriptors
Economics, Medical
Health Care Costs
Health Policy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1515/fhep-2026-frontmatter1
Open DOI
Frontmatter
02
DOI 10.1515/fhep-2025-0034
Open DOI
Valuing Dementia Interventions Under Uncertainty: A Comparison of Generalized and Risk-Adjusted Cost Effectiveness to Traditional Cost-Effectiveness Analyses
Traditional cost-effectiveness analysis (TCEA) overlooks nonlinear patient health preferences, potentially under-valuing health gains for severe diseases and overvaluing health gains for less severe diseases. Generalized and risk-adjuste...
03
DOI 10.1515/fhep-2025-frontmatter2
Open DOI
Frontmatter
04
DOI 10.1515/fhep-2024-0041
Open DOI
How Default Choice and Priority Rule Affects Organ Donation: An Examination of Hypotheses
This paper develops a theoretical model to show how changes in the default system of organ donor registration, along with a Priority Rule, affect society’s cadaveric organ donation rate. The developed model is on the lines of Kessler and...
05
DOI 10.1515/fhep-2025-frontmatter1
Open DOI
Frontmatter
Article Frontmatter was published on June 1, 2025 in the journal Forum for Health Economics & Policy (volume 28, issue 1).
06
DOI 10.1515/fhep-2025-0007
Open DOI
Estimating the Value of Ensifentrine in Addition to Background Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases, leading to increased healthcare use, expenditures, and risk of mortality. In June 2024, the Institute for Clinical and Economic Review (ICER) released ...
07
DOI 10.1515/fhep-2024-0038
Open DOI
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in Neurology
Neurological conditions adversely impact patients and society due to both quality-of-life decrements and high financial burden. Traditional cost effectiveness methods, however, may undervalue neurological treatments by assuming patients ...
08
DOI 10.1515/fhep-2024-frontmatter2
Open DOI
Frontmatter
Article Frontmatter was published on December 1, 2024 in the journal Forum for Health Economics & Policy (volume 27, issue 2).
09
DOI 10.1515/fhep-2024-0052
Open DOI
The Muslim Ban and Preventive Care for Children of Middle Eastern Ancestry
Individuals of Middle Eastern and North African (MENA) ancestry in the US have been the targets of anti-immigrant policies, counterterrorism operations, and vitriolic political rhetoric. Yet, lack of data identifying MENA individuals has...
10
DOI 10.1515/fhep-2024-0049
Open DOI
COVID-19 Biopharmaceutical Innovation and Industry Appropriation
The rapid emergence of vaccines and therapeutics in response to the onset of the coronavirus (COVID-19) pandemic demonstrated the value of medical innovation. These advances not only led to enhanced patient welfare by reducing the diseas...
Bibliographical & Catalog Notes
Description based on first issue; title from title banner (publisher's Web site, viewed Aug. 8, 2008).
Earlier vols.1-7 available in print from MIT Press.
Latest issue consulted: Vol. 11 (2008) (viewed Aug. 8, 2008).
Also issued in print.
Some volumes also called: Frontiers in health policy research.